Last reviewed · How we verify

NCT03061825

Zenith Alpha™ Abdominal Endovascular Graft

Completed Last updated 15 January 2021
What this trial tests

trial testing Zenith Alpha™ Abdominal Endovascular Graft in Abdominal Aortic in 100 participants. Completed in 6 January 2021.

Timeline
24 May 2017
Primary endpoint
6 January 2021
6 January 2021

Quick facts

Lead sponsorCook Research Incorporated
StatusCompleted
Study typeOBSERVATIONAL
Enrollment100
Start date24 May 2017
Primary completion6 January 2021
Estimated completion6 January 2021
Sites5 locations across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Cook Research Incorporated — full company profile →

Who can join

18 and older, any sex, with Abdominal Aortic or Aorto-iliac Aneurysm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the clinical performance of the Zenith Alpha™ Abdominal Endovascular Graft for the treatment of abdominal aortic or aorto-iliac aneurysm.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cook Research Incorporated trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03061825.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing